GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Context Therapeutics Inc (FRA:6K9) » Definitions » Interest Received

Context Therapeutics (FRA:6K9) Interest Received


View and export this data going back to 2021. Start your Free Trial

What is Context Therapeutics Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.


Context Therapeutics (FRA:6K9) Business Description

Traded in Other Exchanges
Address
2001 Market Street, Suite 3915, Unit No. 15, Philadelphia, PA, USA, 19103
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.